Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AURORAX-0087A: Glycosaminoglycan Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic Clear Cell Renal Cell Carcinoma

NCT04006405 is registered in ClinicalTrials.gov with Elypta as lead sponsor.

NCT NCT04006405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04006405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AURORAX-0087A: Glycosaminoglycan Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic Clear Cell Renal Cell Carcinoma
Lead sponsor
Elypta
Phase
Observational
Overall status
Completed
Start date
January 10, 2020
Completion date
May 7, 2025
Enrollment
280 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell renal cell carcinoma